Retraction Retracted : Silymarin Accelerates Liver Regeneration after Partial Hepatectomy Evidence-Based Complementary and Alternative Medicine
暂无分享,去创建一个
L. Pan | Chih-Yang Huang | Yueh-min Lin | Chien-Chung Lin | C. Day | Yu-Lan Yeh | Chia‐Yao Shen | V. Padma | Chin-chuan Tsai | Hepatectomy | Jia-PingWu
[1] A. Dehpour,et al. Possible involvement of nitric oxide in antidepressant-like effect of silymarin in male mice , 2015, Pharmaceutical biology.
[2] H. M. Kutlu,et al. A comparative study on the therapeutic effects of silymarin and silymarin-loaded solid lipid nanoparticles on D-GaIN/TNF-α-induced liver damage in Balb/c mice. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[3] M. Tsironi,et al. Effect of 5-HT7 receptor blockade on liver regeneration after 60-70% partial hepatectomy , 2014, BMC Gastroenterology.
[4] I. Vlachos,et al. Liver regeneration: immunohistochemichal study of intrinsic hepatic innervation after partial hepatectomy in rats , 2014, BMC Gastroenterology.
[5] Y. Liu,et al. Silymarin induces cell cycle arrest and apoptosis in ovarian cancer cells. , 2014, European journal of pharmacology.
[6] S. Hessenberger,et al. Milk Thistle Extract and Silymarin Inhibit Lipopolysaccharide Induced Lamellar Separation of Hoof Explants in Vitro , 2014, Toxins.
[7] N. Udupa,et al. Silymarin liposomes improves oral bioavailability of silybin besides targeting hepatocytes, and immune cells , 2014, Pharmacological reports : PR.
[8] A. Abdel-Naim,et al. Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1α, and NF-κB , 2014, Naunyn-Schmiedeberg's Archives of Pharmacology.
[9] Qingnian Xu,et al. Effects and Tolerance of Silymarin (Milk Thistle) in Chronic Hepatitis C Virus Infection Patients: A Meta-Analysis of Randomized Controlled Trials , 2014, BioMed research international.
[10] F. Tsai,et al. The Effect of Elephantopus scaber L. on Liver Regeneration after Partial Hepatectomy , 2013, Evidence-based complementary and alternative medicine : eCAM.
[11] S. Thorgeirsson,et al. Hepatocyte growth factor/c‐met signaling is required for stem‐cell–mediated liver regeneration in mice , 2012, Hepatology.
[12] K. Kuo,et al. The Activation of MEK/ERK Signaling Pathway by Bone Morphogenetic Protein 4 to Increase Hepatocellular Carcinoma Cell Proliferation and Migration , 2012, Molecular Cancer Research.
[13] O. Hammam,et al. Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis , 2012, Parasites & Vectors.
[14] G. Ferbeyre,et al. SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes. , 2011, Journal of hepatology.
[15] K. Ahmed,et al. The chemopreventive effect of Ginkgo biloba and Silybum marianum extracts on hepatocarcinogenesis in rats , 2011, Cancer Cell International.
[16] S. Katiyar,et al. Silymarin Targets β-Catenin Signaling in Blocking Migration/Invasion of Human Melanoma Cells , 2011, PloS one.
[17] Hyoung‐Chin Kim,et al. Vitamin D3 up-regulated protein 1 deficiency accelerates liver regeneration after partial hepatectomy in mice. , 2011, Journal of hepatology.
[18] C. Loguercio,et al. Silybin and the liver: from basic research to clinical practice. , 2011, World journal of gastroenterology.
[19] H. Baba,et al. Glycine Pretreatment Ameliorates Liver Injury After Partial Hepatectomy in the Rat , 2010, Journal of investigative surgery : the official journal of the Academy of Surgical Research.
[20] R. Agarwal,et al. Multitargeted therapy of cancer by silymarin. , 2008, Cancer letters.
[21] N. Okumura,et al. Cell Surface-Bound Plasminogen Regulates Hepatocyte Proliferation Through a uPA-Dependent Mechanism , 2007, Bioscience, biotechnology, and biochemistry.
[22] S. K. Pandian,et al. Silymarin protection against major reactive oxygen species released by environmental toxins: exogenous H2O2 exposure in erythrocytes. , 2007, Basic & clinical pharmacology & toxicology.
[23] J. Degen,et al. Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor , 2006, BMC gastroenterology.
[24] C. Girish,et al. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. , 2006, The Indian journal of medical research.
[25] J. Armendáriz-Borunda,et al. Urokinase‐type plasminogen activator gene therapy in liver cirrhosis is mediated by collagens gene expression down‐regulation and up‐regulation of MMPs, HGF and VEGF , 2006, The journal of gene medicine.
[26] T. Ikejima,et al. The roles of Akt and MAPK family members in silymarin's protection against UV-induced A375-S2 cell apoptosis. , 2006, International immunopharmacology.
[27] P. Steinberg,et al. Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K/AKT signaling pathway. , 2003, Biochemical and biophysical research communications.
[28] D. Carrier,et al. Extraction of nutraceuticals from milk thistle , 2003, Applied biochemistry and biotechnology.
[29] N. Fausto,et al. Role of growth factors and cytokines in hepatic regeneration , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] G. Park,et al. Silymarin induces cyclin D1 proteasomal degradation via its phosphorylation of threonine-286 in human colorectal cancer cells. , 2015, International immunopharmacology.
[31] J. Féher,et al. Silymarin in the prevention and treatment of liver diseases and primary liver cancer. , 2012, Current pharmaceutical biotechnology.
[32] F. Burczynski,et al. Silymarin and hepatoprotection. , 2012, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.
[33] R. Saller,et al. The Use of Silymarin in the Treatment of Liver Diseases , 2012, Drugs.
[34] Abigail S. Engelberth,et al. Extraction of Co-Products from Biomass: Example of Thermal Degradation of Silymarin Compounds in Subcritical Water , 2009 .
[35] G. Michalopoulos,et al. Liver regeneration. , 2005, Advances in biochemical engineering/biotechnology.
[36] H. Tilg,et al. Silymarin: A Review of its Clinical Properties in the Management of Hepatic Disorders , 2001 .